BOONE CAPITAL MANAGEMENT LLC — 13F Holdings & Portfolio
CIK 1882053 · latest 13F-HR filed 2026-05-15
BOONE CAPITAL MANAGEMENT LLC manages $326.4M in 13F-reported U.S. long-equity assets across 13 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are MIRM (11.92%), IONS (11.51%), CI (11.24%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 5 new positions, exited 7, added to 6, and trimmed 2.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$326.4M
Long-equity book
13
Distinct positions
2026-03-31
Filed 2026-05-15
+5 / −7 / ↑6 / ↓2
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- THE CIGNA GROUP$10.1M +38.2%
- BIOMARIN PHARMACEUTICAL INC$6.5M +26.4%
- MIRUM PHARMACEUTICALS INC$5.6M +17.0%
- IONIS PHARMACEUTICALS INC$4.5M +13.7%
- BRIDGEBIO PHARMA INC$2.8M +20.1%
New Positions
- TELEFLEX INCORPORATED$33.3M
- GUARDIAN PHARMACY SVCS INC$23.8M
- ASTRAZENECA PLC$21.7M
- AVANOS MED INC$16.6M
- TENAX THERAPEUTICS INC$3.2M
Exited Positions
- NEUROCRINE BIOSCIENCES INC$21.5M
- ASTRAZENECA PLC$20.2M
- HEALTHEQUITY INC$19.5M
- LIVANOVA PLC$17.8M
- RAPT THERAPEUTICS INC$15.9M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | MIRUM PHARMACEUTICALS INC | MIRM | 604749101 | $38.9M | 11.92% | 421,236 | SH |
| 2 | IONIS PHARMACEUTICALS INC | IONS | 462222100 | $37.6M | 11.51% | 500,522 | SH |
| 3 | THE CIGNA GROUP | CI | 125523100 | $36.7M | 11.24% | 137,522 | SH |
| 4 | MEDTRONIC PLC | MDT | G5960L103 | $34.5M | 10.57% | 398,065 | SH |
| 5 | TELEFLEX INCORPORATED | TFX | 879369106 | $33.3M | 10.22% | 278,792 | SH |
| 6 | BIOMARIN PHARMACEUTICAL INC | BMRN | 09061G101 | $30.9M | 9.48% | 547,871 | SH |
| 7 | GUARDIAN PHARMACY SVCS INC | GRDN | 40145W101 | $23.8M | 7.28% | 631,193 | SH |
| 8 | ASTRAZENECA PLC | AZN | G0593M107 | $21.7M | 6.65% | 110,101 | SH |
| 9 | UNITEDHEALTH GROUP INC | UNH | 91324P102 | $21.4M | 6.57% | 79,226 | SH |
| 10 | BRIDGEBIO PHARMA INC | BBIO | 10806X102 | $17.0M | 5.21% | 228,829 | SH |
| 11 | AVANOS MED INC | AVNS | 05350V106 | $16.6M | 5.09% | 1,184,909 | SH |
| 12 | KODIAK SCIENCES INC | KOD | 50015M109 | $10.7M | 3.29% | 281,332 | SH |
| 13 | TENAX THERAPEUTICS INC | TENX | 88032L605 | $3.2M | 0.98% | 200,000 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | $326.4M | 13 | 0001214659-26-006448 |
| 2025-12-31 | 2026-02-17 | $318.6M | 15 | 0001214659-26-001960 |
| 2025-09-30 | 2025-11-14 | $305.0M | 16 | 0001214659-25-016617 |